Molecular Imaging Market, By Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), By Application (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder, Lung Disorder, Bone Disorder, and Others) By End User (Hospital, Diagnostic Imaging Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI32219 | Publish Date: March 2024 | No. of Pages: 178

Global Molecular Imaging Market By Overview

Molecular imaging is a discipline that integrates molecular biology, cell biology, and diagnostic imaging, which is used for various clinical application that include the use of nuclear medicine, magnetic resonance imaging and ultrasound.  The molecular imaging has two basic applications, first is diagnostic imaging used to determine the location and extent of targeted molecules specific to the disease and second is a therapy used to treat specific disease-targeted molecules. Also, it has the potential to have a significant influence on healthcare sector by early diagnosis, evaluating disease severity, and use of personalized treatment. The global molecular imaging market accounted for US$ 6.8 billion in 2019 and is estimated to be US$ 13.7 billion by 2029 and is anticipated to register a CAGR of 7.3%.

Impact of Covid-19 pandemic on market

The coronavirus, or COVID-19, epidemic, which began in Wuhan, China, has spread across continents, affecting a wide range of businesses. Due to forced quarantine and a scarcity of manpower and raw supplies, the supply of critical goods has been severely interrupted. Regional warehouse operations are inefficient, and raw materials cannot be transported successfully between areas. As a result of the scarcity of raw materials and components, the worldwide molecular imaging equipment market's supply chain has been disrupted. Molecular imaging methods utilized for the identification and management of COVID-19, such as positron emission tomography/computed tomography (PET/CT), boosted the worldwide molecular imaging market growth during the pandemic.

Global Molecular Imaging Market By Dynamics

Increasing number of affected individuals, healthcare advancement & machine learning will drive the Global molecular imaging market in future.

The increasing prevalence of cancer, neurological and cardiovascular disease is expected to propel the molecular imaging market. Also, rising number of government initiatives, rising trends of preventive healthcare and disease screening programs, the technological advancements & increasing investments in the non-invasive techniques for early detection of cardiology or oncology-specific diseases are expected to drive this market in forecast period. Furthermore, increasing machine learning based approach in this sector will provide accurate detection which results into increase the growth rate of this market.

High cost & demand of refurbished products expected to hampers the Global molecular imaging market in future.

There are few restrains to the market due to limitations associated with all molecular imaging modalities which include, lack of penetration depth, and side effects of radiation is expected to hamper the growth of global molecular imaging market. Also, the lack of skilled professionals required to operate instruments is a major factor that can restrain the growth of the market for molecular imaging.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Molecular Imaging Market By Segmentation

The molecular imaging market has been segmented on the basis of technology, application, end-user and region.

The Technology segment includes Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging

On the basis of application the target market has been segmented as Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder, Lung Disorder, Bone Disorder, and Others.

Based on end user, the market has been segmented into Hospital, Diagnostic Imaging Centers, and Others.

Regional Insights:

On region the global molecular imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the target market during forecast period due to increasing number of cancer patients. For instance, as per the report of American Cancer Society, prostate, lung, bronchus, and colorectal cancers account for 42% of all cases in men. Whereas, breast, lung, and colorectal cancers account for 30% of all cancers in women. Germany is also expected to represent lucrative growth in forecast period due to rising partnerships & collaborations of companies as well as increasing oncology care units.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Technology Type – Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging.

 

By Application - Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder, Lung Disorder, Bone Disorder, and Others.

 

By End User- Hospital, Diagnostic Imaging Centers, and Others.

 

 

 

 

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

 

 

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global molecular imaging market report based on technology, application, end-user & region.

Molecular Imaging Market, By Region:

  • North America
      • U.S.
        • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Molecular Imaging Market By Key Players

The key players operating in the  molecular imaging market includes the prominent players such as Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation.

Global Molecular Imaging Market By Company Profile

  • Carestream Health
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Fujifilm Holdings Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  •    Philips Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Hitachi Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GE Healthcare Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Samsung Medison
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Toshiba Medical Systems Corporation.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Philips Healthcare Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Shimadzu Medical Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Siemens AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

 

 “*” marked represents similar segmentation in other categories in the respective section

Global Molecular Imaging Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Molecular Imaging Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End-user
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Molecular Imaging Market, By Technology, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Gamma Camera
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • SPECT
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • PET
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Magnetic Resonance Spectroscopy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Optical Imaging
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Molecular Ultrasound Imaging
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  6. Molecular Imaging Market, By Application, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Heart Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Brain Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Gastrointestinal Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Lung Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Bone Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  7. Molecular Imaging Market, By End-user, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Diagnostic Imaging Centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  8. Molecular Imaging Market, By Region, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
      • Market Size  and Forecast (US$ Mn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • Carestream Health
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Fujifilm Holdings Corporation
      • GE Healthcare
      • Hitachi Ltd.
      • Hologic, Inc.
      • Siemens AG
      • Philips Healthcare
      • Samsung Medison
      • Shimadzu Corporation
      • Toshiba Medical Systems Corporation
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global molecular imaging market is segmented based on Technology, Application, End user & Region.

Increasing rate of cancer and cardiac patients, rising number of government initiatives, rising trends of preventive healthcare and disease screening programs, technological advancements, Machine learning based approach are expected to drive this market in forecast period.

North America, followed by Europe are expected to dominate market in future due to increasing hospital infrastructure & healthcare technological advancement.

Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hitachi Ltd Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation.